1
/
of
0
FDA Drug/Biologics Approval BLA 125166 S-422, ECULIZUMAB
FDA Drug/Biologics Approval BLA 125166 S-422, ECULIZUMAB
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
BLA 125166 S-422
Company: ALEXION PHARM
Drug Name: SOLIRIS
Active Ingredients: ECULIZUMAB
Strength: 300MG
Dosage Form/Route: INJECTABLE; IV (INFUSION)
Action Date: 03/16/2007
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: ALEXION PHARM
Drug Name: SOLIRIS
Active Ingredients: ECULIZUMAB
Strength: 300MG
Dosage Form/Route: INJECTABLE; IV (INFUSION)
Action Date: 03/16/2007
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details